Friday, January 29, 2021

Lupine Publishers | Language Development as An Objective Indicator of Neurodevelopment

 Lupine Publishers | Journal of Otolaryngology


Short Communication

Language development is an objective indicator of developmental and cognitive skills in children. It is also one of the fundamental pillars for a child to acquire autonomy and be able to adapt to social and academic situations. A language delay (including both verbal and non-verbal skills) is an indicator that some aspect of development in young children is not going well. Language delays may be primarily due to four causes: hearing problems, neurodevelopmental conditions, such as the risk of having Developmental Language Disorder (DLD, formerly Specific Language Impairment –SLI-), Intellectual Disability -which at an early age is labeled as Developmental Global Disorder (DGD), or Autism Spectrum Disorder (ASD).

Hearing Problems

According to WHO (2000), 10% of children are born deaf or hard-to-hearing. To a large extent, neonatal hearing screening can detect most of individuals with hearing loss, when there is a genetic or congenital etiology. Birth defects also include hearing loss and congenital deafness; it is estimated that between 2,000 and 6,000 children are born with these conditions each year in Mexico [1]. However, for those individuals with mild or moderate hearing loss, which is not detected by neonatal screening, a delay in language development can be evidenced around eighteen months of age. For example, recurrent otitis media has been known to contribute to language delays in young children under 2 years of age. However, a systematic review informed that it only contributes to phonological deficits in children [2]. Recurrent otitis interferes with the quality of the sound signal received by the child, especially the perception of some phonemes (e.g. fricative and voiceless sounds) but is not directly related to language and communication delays.

Late Talkers (LT)

When hearing loss is excluded as the cause of language delays, the developmental condition to be considered as the most prevalent is “Late Talker” (LT). According to various authors [3-5], this condition exhibits a prevalence of 13.5%, which is not caused by sensory, anatomical or neurological problems. The delay is primary manifested, but not exclusively, in the domain of expressive language (production of gestures, words and sentences) [6,7]. About 70-75% of LTs will catch up to their peers at 36 months of age. But approximately 25-30% of these children will continue with more severe language difficulties, which may evolve into a Developmental Language Disorder (DLD) [8]. Most of the studies about LTs agree that these children produce less than 50 words [9,10] and have not combined words at 24 months [11,12]. In many cases, children under the age of three, who speak little or not at all, go unnoticed at school or clinical services, since initial language delays are generally not considered a major problem that should be addressed by the health and/or education system.

Intellectual Disability (ID)

Neonatal metabolic screening is mandatory in many countries, and since 1998, it has been performed in all newborns in Mexico. This screening can detect congenital or metabolic conditions that can be treated promptly to prevent irreversible conditions such as ID. According to WHO [13], the frequency of congenital anomalies in the world is 2 to 3% in live births. However, there is still a big proportion of children with a risk of ID that go undetected in developing countries. In a recent study, Rizzoli Córdoba [14] reported that 4.2% of children were at risk of delay, being the communication and cognition domains the most affected at 24 months of age. Although the diagnosis of ID cannot be established until the psychometric measurement of IQ around the age of 4, the data suggests that in developing countries, Global Developmental Delay [15] with communication, cognition and other developmental domains affected might be more pervasive due to socio-demographic associated factors, such as the insufficient consumption of nutrients during pregnancy, poorer access to healthcare and screening, among others. According to WHO [13], it is estimated that about 94% of severe congenital anomalies occur in low- and middle-income countries. Moreover, in these countries 39% of children younger than 5 years, might be at risk of not reaching their developmental potential [16].

Autism Spectrum Disorder (ASD)

In the third order of prevalence, language delays in young children may be associated with the risk of presenting ASD, which is characterized by difficulties in the use of social communication (among other features), although said difficulties are not exclusively pragmatic [17]. This condition is frequent in neurodevelopmental disorders being present in about 1% of the children [18]. At least half of the children with ASD who develop language, lag behind their peers in phonological processing, use of gestures, symbolic play and social routines, expressive and receptive vocabulary, grammar (morphology and syntax), and pragmatics (social use of language). Early delays include social difficulties to establish joint attention with adults and peers, lack of response to their names, problems initiating social play and a reduced production of gestures and symbolic play. Said delays, specifically those with difficulties to establish joint attention and the lack of response to their own names, commonly mislead parents into falsely suspecting their child might have hearing problems. Moreover, delays on social and communicative outcomes, are sometimes unseen by health and education professionals.

What is recommended?

Although neonatal metabolic and hearing screenings are good sources for early detection of some conditions that affect child development, one of the greatest challenges for developing countries is to establish screening models that are useful for early detection of language delays before 30 months of age. No recommendations exist for screening language delays at these ages, being early identification a big challenge. An implication of this review is twofold: First, typical developmental language benchmarks of children under 30 months of age should be well known among primary health care clinicians, pediatricians, otolaryngologists, neurologists and preschool educators in order to early identify language delays. Second, identification of language delays under three years of age can serve as an important step forward for public health, because language can just be a symptom of a developmental condition. Finally, there is sufficient evidence supporting the effectiveness of treating language delays and disorders in children [19]. The development of expressive language, mainly the onset of first gestures, words and phrases is a relevant clinical tool, since its early appearance is associated to better long-term life outcomes and to better prognosis [20]. Early identification can help them receive a diagnosis and reduce the negative impact of any of these conditions throughout life.

Read More Lupine Publishers Otolaryngology Journal Articles:
https://lupine-publishers-otolaryngology.blogspot.com/

 

Friday, January 22, 2021

Lupine Publishers | Allegric Rhinitis: Pearls of Wisdom

 Lupine Publishers | Journal of Otolaryngology


Abstract

Statement of The Problem

This provides an overview of Allergic Rhinitis and its management. It is very useful for students of Rhinology and clinicians managing this disease. It introduces them to a systematic approach of assessing allergic rhinitis patients which is very commonly found in most populations and causes considerably morbidity. Allergy per se is a very difficult subject to master and it is with great perseverance one can treat patients suffering from this condition. The cornerstone of managing a patient of allergic rhinitis is first and foremost obtaining a good history. This is to be followed by a thorough examination and investigations. The general practitioner is the first expert to be involved in management of allergic rhinitis patient followed by specialists otorhinolaryngologists, and finally by allied healthcare personnel. Inflammation of nose and paranasal sinuses are characterized by two or more symptoms-namely, either nasal blockage; obstruction; congestion or nasal discharge. Associated symptoms include facial pain; pressure and either reduction or loss of smell. Certain diagnostic endoscopic signs of nasal polyps and or mucopurulent discharge and or mucosal oedema in the middle meatus and or CT changes of mucosa within the ostoemeatal complex, and or sinuses are seen. Definitions, aetiologies, clinical presentations, diagnosis; prognosis and management of allergic rhinitis is dealt with. Common allergens causing the disease are mentioned, pathophysiology and classification of allergic rhinitis is discussed in detail. Different types of allergen testing are highlighted along with their specific role and uniqueness. Principles of immunotherapy in treatment of allergic rhinitis are discussed here. Health effects of allergic rhinitis along with its impact on physical quality of life is mentioned. The basic idea of this presentation is to improve diagnostic accuracy by promoting appropriate use of ancillary tests like nasoendoscopy, allergy testing, computed tomography etc. and reduce inappropriate antibiotic use. The basic treatment plan of allergic rhinitis is according to the severity and duration. It consists of allergen avoidance, pharmacotherapy, allergen immunotherapy and surgery which has limited role.

Keywords: Allergy; Rhinitis; Pollens; Molds; Insects; Penicillium; Cladosporium; Hypersensitivity; Histamine; Hay fever; Rose Fever; Transverse Nasal Crease; Rhinorrhea; Allergic Salute; Allergic Shiners (Dennie -Morgan Lines); Cobblestone Appearance Of Oropharynx; Scratch Test ; Intradermal Test; Patch Test; Rhinomanometry; Antihistaminics; Immunotherapy; Topical Nasal Steroids; Cochrane; Mast Cell Stabilizer

Abbreviations: IgA: Immunoglobulin A, IgE: Immunoglobulin E, AR: Allergic Rhinitis; NAR: Non-Allergic Rhinitis; ARIA: Allergic Rhinitis & its Impact on Asthma; Greater than; Less than; TM: Tympanic membrane; NPT: Nasal Provocation Test; n NO: Nitrogen in Nitric Oxide; PNS: Para Nasal Sinuses; OM: Occipito Mental; CECT: Contrast Enhanced Computerized Scan; L.A: Local Anaesthesia GA: General Anaesthesia; PQLI: Physical Quality of Life Index; WAO: World Allergy Organization; SCIT: Subcutaneous immunotherapy; SLIT: Sublingual immunotherapy; AIT: Allergic Immunotherapy; e-Health: Electronic Health; DBPC: Double Blind Placebo Controlled; RCT: Randomized Controlled Trial; FDA: Food & Drug Administration federal agency in USA; SMD: Submucous Diathermy; IT: Inferior turbinate; FESS: Functional Endoscopic Sinus Surgery; OMC: Osteo Meatal Complex

Introduction

Rhinitis is a common presentation in E.N.T. clinics across the globe & allergy compounded with it causes even more difficult to treat for the clinician. This article is useful and handy for students and clinicians managing Allergy& Rhinitis. There is something in this for everyone-General Practitioners, Otorhinolaryngologists, Allergologists, Rhinologists and Allied Healthcare personnel. Special computer based newer modalities of investigations are highlighted in this which helps in assessing the nasal function of the affected patient. It’s very common to sometimes feel like sneezing & have running nose but please see a doctor if the feeling persists and do take care of yourself. Allergic Rhinitis is made so easy to comprehend. Nasal function includes temperature regulation, olfaction, humidification, filtration and protection [1]. Nasal lining contains secretion of IgA, proteins and enzymes. Nasal cilia propel the matter towards the natural ostia at frequency of 10-15 beats; min. Mucous moves at a rate of 2.5 -7.5ml. per min (Figure 1). Rhinitis is the presentation of two or more nasal symptoms for more than one a day namely Nasal congestion; obstruction, Rhinorrhea, Sneezing, Itching, Impairment of smell. Rhinitis occurs most commonly as Allergic Rhinitis. Non-infectious rhinitis has been classified as either Allergic or Non-Allergic Rhinitis. Allergic Rhinitis affects 15-30% of population with a wide geographic variance. It is more common in children & adolescents. 50% of all rhinitis in E.N.T. Clinics is Allergic Rhinitis. Allergic Rhinitis is defined as immunologic nasal response, primarily mediated by IgE. Non-Allergic Rhinitis is defined as rhinitis symptoms in the absence of identifiable allergy, structural abnormality or sinus disease. So, Allergic Rhinitis is an inflammation of the nasal mucosa, caused by allergen. It is the most common Atopic allergic reaction.

Figure 1: The Human Normal Eye Anatomy.

Lupinepublishers-openaccess-otolaryngology-journal

Aetiology

Aetiology is classified as Precipitating factors and Predisposing factors. Precipitating factors are classified into aerobiological flora and nasal physiology. Aerobiological flora are Allergens present in the environment, House dust & dust mites, Feathers, Tobacco smoke, Industrial Chemicals and Animal dander. Nasal physiology are Disturbances in normal nasal cycle. Predisposing factors are classified into genetic, endocrine, psychological, focal sensitivity tests, infections, physical, age & sex, IgA deficiency and common allergens [2]. Genetic factors indicate towards Multiple gene interactions are responsible for allergic phenotype. Chromosomes 5,6,11,12 & 14 control inflammatory process in atopy. 50% of AR pts. Have positive family history. Endocrine factors are Puberty, Pregnancy; Postpartum stages and Menopause. Infections such as Fungal. Physical factors are Degree of pollution of air, Humidity & Temperature differences, Temperature changes. Common allergens such as pollens (Spring tree pollens (Maple ; Alder ; Birch), Summer grass pollen (Blue grass, Sheep sorrel etc.), Autumn Weed pollen (Ragweed)), molds) Penicillium, Cladosporium etc.), INSECTS (Cockroaches, Houseflies, Fleas, Bedbugs) (Figure 2). Rhinitis is the presentation of two or more nasal symptoms for more than one a day namely Nasal congestion; obstruction, Rhinorrhea, Sneezing, Itching, Impairment of smell. Rhinitis occurs most commonly as Allergic Rhinitis. Non-infectious rhinitis has been classified as either Allergic or Non-Allergic Rhinitis. Allergic Rhinitis affects 15-30% of population with a wide geographic variance. It is more common in children & adolescents. 50% of all rhinitis in E.N.T. Clinics is Allergic Rhinitis [3]. Allergic Rhinitis is defined as immunologic nasal response, primarily mediated by IgE. Non-Allergic Rhinitis is defined as rhinitis symptoms in the absence of identifiable allergy, structural abnormality or sinus disease. So, Allergic Rhinitis is an inflammation of the nasal mucosa, caused by allergen. It is the most common Atopic allergic reaction.

Figure 2:

Lupinepublishers-openaccess-otolaryngology-journal

Pathophysiology

Immunoglobulin IgE mediated type 1 hypersensitivity response to an antigen (allergen) in a genetically susceptible person. IgE is produced from plasma cells & the process is regulated by T-Suppressor lymphocytes or T-helper cells. IgE has affinity for mast cells & basophils and gets fixed to the surface of mast cells by its Fc end. Type 1 Hypersensitivity causes local vasodilation & increased capillary permeability. There is edema of the submucosal tissue by allergic fluid followed by infiltration by eosinophils and plasma cells leading to vascular dilatation which causes engorgement of the inferior turbinates and there is increased activity of seromucinous glands [4]. Histamine exerts its pharmacologic effect on smooth muscle, vascular endothelium & mucous glands. Number of IgE molecules has been estimated as 5300 to 27,000 in non-allergic subject & 15,000 to 41,000 in allergic subjects. Hypersensitivity of the host depends on antigen dose, frequency of exposure, genetic make-up, and hormone activity of the body.

Classification

Allergic Rhinitis is currently classified into intermittent and persistent. In intermittent AR the symptoms are present less than 4 days per week and less than 4 weeks per year [5]. In persistent AR the symptoms are present for greater than 4 days per week and for greater than 4 weeks per year. The severity of AR is classified into mild and moderate to severe. Mild AR doesn’t interfere with daily activities or doesn’t produce any troublesome symptoms. Moderate to severe AR interferes at least with one of the factors such as impaired sleep, hampered daily activities/work, school/ sick absenteeism, also produces troublesome symptoms. AR is formerly classified into seasonal and perennial based on the allergens. Seasonal Hay Fever, misnomer- no hay/no fever. Summer Cold caused by viruses causing URTI. Rose Fever seen usually in Indian Subcontinent (colorful/fragrant flowering plants). Perennial Allergens present throughout the year.

Signs and symptoms of AR

Symptoms of AR are sneezing, itching of eyes, ears & palate, rhinorrhea, postnasal drip, congestion, anosmia, headache, otalgia, epiphora, red eyes, swollen eyes, fatigue, drowsiness and malaise.

Figure 3(a): Transverse Nasal Crease

Lupinepublishers-openaccess-otolaryngology-journal

Figure 3(b): Allergic salute

Lupinepublishers-openaccess-otolaryngology-journal

Figure 3(c): Allergic shiners (Dennie-Morgan lines).

Lupinepublishers-openaccess-otolaryngology-journal

Figure 3(b): Cobblestone appearance of oropharynx.

Lupinepublishers-openaccess-otolaryngology-journal

Physical Examination: During Physical examination we check for TRANSVERSE NASAL CREASE (Horizontal crease across the lower half of the bridge of nose), RHINORRHOEA (Thin watery secretions from nose) (Figure 3). Associated features with AR are Injected & swelling of palpebral conjunctiva with excess tearing, Retracted T.M.’s, Overbite, Periorbital oedema.

Investigations

Skin prick tests---gold standard. This is also known as Scratch Test; Intradermal Test. Controlled amounts of allergen & control substances are introduced into the skin this procedure is convenient, safe & widely accepted (Figure 4). Goal of the investigation is the detection of immediate allergic response caused by release of mast cells or basophil IgE specific mediators Wheal; Flare after 15 mins [6]. More investigations are such as RAST-Radio-Allergo-Sorbent Test for specific IgE estimation. PRIST-Plasma Reactive Immuno- Sorbent Test for specific IgE estimation. SET Test-Skin End-Point Titration Test Latest skin test for allergy & is more reliable. Less common tests are total serum IgE, total blood eosinophil count, nasal smears may show increased eosinophilic level, PATCH TEST is used to determine delayed type hypersensitivity & the allergen is placed in the skin for 48hrs [7]. The area of reaction is noted and if any allergens present are identified. This is more useful in skin problems & food allergy.

Figure 4:

Lupinepublishers-openaccess-otolaryngology-journal

a) Nasal provocation tests (NPT)

Figure 5(a): Rhino meter.

Lupinepublishers-openaccess-otolaryngology-journal

Figure 5(b): Spraying Device for NPT.

Lupinepublishers-openaccess-otolaryngology-journal

The potential allergen is sprayed into the nose & the number of SNEEZES counted or any change in Rhinomanometry is noted. Very time-consuming test as each allergen takes 20 mins. To test in order to allow the nose to return to normal after the challenge. It is useful for rare & occupational allergens. Contraindications of NPT are Pregnancy; < 5yrs. age; Recent nasal surgery <8 wks; Uncontrolled asthma, Nasal; systemic corticosteroids should be avoided for 1wk & Antihistaminics for 72hrs (Figure 5).

New Diagnostic Methods

Exhaled Nitric Oxide (E No): Like e NO in asthma, n NO is a noninvasive marker. Potentially suitable to monitor upper airway inflammation following allergen-induced late response. In AR pts., increased levels of n NO have been measured. However, the applicability of n NO as a marker of upper airway inflammation awaits validation. Exhaled nitric oxide (e NO) is currently the MOST RELIABLE MARKER of rhino-bronchial inflammation, but its routine assessment is difficult as the test is available only in highly specialized centers.

Other Investigations

X-RAY PNS-Water’s (OM view). CECT of PNS…2mm. Coronal cuts are preferred. NASOENDOSCOPY. under L.A.; G.A. Hopkins rod 0º; 30º; 70º). Evaluate the individual for asthma. At some centres FAST-Fluro Allergo Sorbent Test is done.

Complications of AR

Complications of AR are allergic asthma, chronic otitis media, hearing loss, chronic nasal obstruction, sinusitis, orthodontic malocclusion in children (Figure 6).

Figure 6: The Human Normal Eye Anatomy.

Lupinepublishers-openaccess-otolaryngology-journal

Prognosis

Treatment is available & pts. remain asymptomatic only until re-exposure to allergic antigen. There is no evidence of mortality from the disease but there is very high morbidity. PQLI is affected. Seasonal allergic symptoms improve as patients age.

Management of AR

Management of Allergic Rhinitis includes Allergen avoidance & environmental control measures, Medical; pharmacologic treatment, Immunotherapy and Surgery [8]. Choice of treatment will depend on efficacy, safety, cost-effectiveness, patient preferences, combination, objectives of treatment, likely adherence to recommendations, severity & control of disease and presence of co-morbidities. Practical allergen avoidance tips given by WAO for public education purposes are as follows in (Figure 7).

Figure 7: The Human Normal Eye Anatomy.

Lupinepublishers-openaccess-otolaryngology-journal

Pharmacotherapy

Oral antihistaminic are

1ST GEN: - Chlorpheniramine maleate; Diphenhydramine; Clementine.

2ND GEN: - Loratadine; Terfenadine; Acrivastine

3rd GEN.: - Fexofenadine; Cetrizine. Topical application of Azelastine.

NEWER - Desloratadine; Levocetrizine.

Acute Phase Medications

Antihistaminics are effective in blocking histaminic effects. (Runny nose; Watery eyes). Side Effects of antihistaminics are Sedation, Dry mouth, Nausea, Dizziness, Blurred vision, Nervousness. Non-sedating antihistaminics (Cetirizine; Loratadine) has fewer side effects. Fexofenadine is more effective (has a lower risk of cardiac arrythmias). Decongestants will Shrink mucous membranes by vasoconstriction. These are available OTC; in combination with antihistaminic, analgesics & anti cholinergic [9]. Anticholinergic Agents Inhibit mucous secretions which acts as drying agents. Topical Eye Preparations reduces inflammation; relieves burning and itching (Figure 8).

Figure 8:

Lupinepublishers-openaccess-otolaryngology-journal

Preventive Therapy

Intranasal Corticosteroids Reduces inflammation of mucosa, prevents mediator release, can be used safely daily, can be given systemically as a short course during a disabling attack. Intranasal Cromolyn Sodium Mast cell stabilizer Prevents release of chemical mediators. Oral Mast Cell Stabilizer, Ophthalmic solution cromolyn. Topical nasal steroids are dexamethasone, beclomethasone dipropionate, triamcinolone acetonide, flunisolide, budesonide, fluticasone propionate, mometasone furoate and ciclesonide [10]. LEUKOTRIENE RECEPTOR ANTAGONISTS (ANTI LEUKOTRIENE AGENTS) are MONTELEUKAST(Singular); ZAFIRLEUKAST(Accolate) & PRANLEUKAST. These drugs reduce inflammation, oedema & mucous secretions of Allergic Rhinitis. ZILEUTON (5-Lipoxygenase inhibitor) is a similar drug & is used in many parts of the world.

Immunotherapy (AIT)

SCIT is effective in seasonal pollinosis & mite allergy. SLIT is Effective & safe alternative, best in seasonal AR. COCHRANE reviews shows that both are equally effective & the patient is in equipoise. These are more effective in adult pts. 3yrs. Of treatment with both SCIT & SLIT has been shown to provide long term clinical benefits for at least 2 yrs. after their discontinuation. The choice of therapy depends on grounds of convenience, availability of resources & personal preferences. SCIT requires administration in a specialist clinic whereas SLIT can be self-administered.

Current Concepts & Future Needs

Although AIT is considered a safe & effective treatment for AR, however, its clinical effect is still contested by many due to: Heterogenicity in clinical trial designs, Study populations, Therapeutic formulations, Efficacy criteria. There is ample scope for physicians, patient organizations, companies & regulators to improve clinical trials in AIT and, to provide patients with better treatments. Inclusion of allergic pts. with relevant diseases(s) in AIT trials. Exclusion of polyallergic pts. (with clinically relevant, overlapping allergen exposures) in AIT trials. Clinically defined responders in AIT trials. Allergen exposure chambers in AIT trials. Differences in regional & seasonal exposures. Adaptive trial designs should be discussed with regulatory bodies. Patient-to-patient differences in treatment adherence & allergen exposure. (Use of “e-health” is recommended). The placebo effect in AIT is to be considered. Ethical & technical aspects of DBPC; RCT’s, especially in paediatric populations. The importance of safety reporting. (WAO guidelines for reporting systemic & local adverse events should be applied).

Omalizumab for Treatment of AR

Figure 9:

Lupinepublishers-openaccess-otolaryngology-journal

(Figure 9) This is a new treatment strategy for allergic rhinitis DBPC study of RAGWEED immunotherapy7 is done. Prohibitive high cost. It is not FDA approved for this indication. Periodic use is justified in treatment of resistant patients especially those with seasonal disease. This drug acts by removal of circulating free IgE by the recombinant humanized monoclonal anti IgE antibody.

Surgical Treatment: Surgical treatment has limited use, SMD of I.T. reduces the size of boggy turbinates. Septoplasty is done for the Correction of septal deviation. FESS is done for the Clearance of sinuses and OMC If indicated. VIDIAN Neurectomy is done in certain selected cases.

Surprising Relief for Stuffy Nose: Sex: According to Dr. Michael Benninger, Otolaryngologist, Chairman of Cleveland Clinic’s Head & Neck Institute, in a study done in May 2018 has some surprising findings. The potential effect of sexual activity works the same for man & women. Swollen tissues in nose block the passages in AR creating congestion & making it harder to breathe. During arousal, the Sympathetic NS gets into play, adrenaline levels go up & blood vessels constrict. Less blood flow to the nose means less inflammation, so the nose opens up & one can breathe more easily. Lying on back position for both men and women, one cannot experience the same level of congestion relief due to effects of gravity.

Stepladder Approach in Treatment of AR: (Figure 10) Allergic Rhinitis Guide: Frequently Asked Questions (FAQ’S)

Figure 10:

Lupinepublishers-openaccess-otolaryngology-journal

a) What is common medication mistake that people make?

b) How long should one stay on allergy treatment?

c) How can one differentiate between common cold & AR?

d) What are the side effects of allergy medications?

e) How to use nasal sprays? (Figure 11)

Figure 11:

Lupinepublishers-openaccess-otolaryngology-journal

f) Are the steroids in nasal sprays safe?

g) What is the difference between the nasal medications & oral medications?

h) How quickly can one expect to get relief from allergy treatment?

i) Taking corticosteroids inhalers to control asthma symptoms, can one also take allergy medications?

j) What are the types of allergy tests? IgE skin test; Intradermal test; Specific IgE in blood.

 

Read More Lupine Publishers Otolaryngology Journal Articles:
https://lupine-publishers-otolaryngology.blogspot.com/

 

Choanal Atresia Repair, A Comparison Between Transnasal Puncture With Dilatation And Stentless Endoscopic Transnasal Drilling

  Abstract Background: in this study we present the outcome of surgical repair of choanal atresia of 33 patients underwent t...